1. Antibacterial properties of nitric oxide-releasing porous silicon nanoparticles
- Author
-
M. Hasanzadeh Kafshgari, Nicolas H. Voelcker, Alex Cavallaro, Jarno Salonen, Ermei Mäkilä, Krasimir Vasilev, Bahman Delalat, Frances J. Harding, Kafshgari, M Hasanzadeh, Delalat, B, Harding, FJ, Cavallaro, A, Mäkilä, E, Salonen, J, Vasilev, K, and Voelcker, NH
- Subjects
Materials science ,efficacy ,Biomedical Engineering ,Nanoparticle ,Nanotechnology ,02 engineering and technology ,Bacterial growth ,Conjugated system ,010402 general chemistry ,Porous silicon ,medicine.disease_cause ,01 natural sciences ,Nitric oxide ,chemistry.chemical_compound ,medicine ,silver ,General Materials Science ,bacteria ,Escherichia coli ,ta114 ,biology ,General Chemistry ,General Medicine ,021001 nanoscience & nanotechnology ,biology.organism_classification ,Ascorbic acid ,0104 chemical sciences ,antibiotic-resistance ,chemistry ,0210 nano-technology ,Bacteria ,wound care ,Nuclear chemistry - Abstract
In this study, the antibacterial efficacy of NO-releasing porous silicon nanoparticles (pSiNPs) is reported. NO-releasing pSiNPs were produced via the conjugation of S-nitrosothiol (SNO) and S-nitrosoglutathione (GSNO) donors to the nanoparticle surfaces. The release of the conjugated NO caused by the decomposition of the conjugated SNO and GSNO was boosted in the presence of ascorbic acid. The released NO was bactericidal to Gram-positive (Staphylococcus aureus) and Gram-negative bacteria (Escherichia coli), and eliminated bacterial growth within 2 h of incubation without compromising the viability of mammalian cells. These results demonstrate the advantages of NO-releasing pSiNPs for antibacterial applications, for example, in chronic wound treatment. Refereed/Peer-reviewed
- Published
- 2020